References
- Sinaii N, Cleary SD, Younes N, et al. Treatment utilization for endometriosis symptoms: a cross-sectional survey study of lifetime experience. Fertil Steril 2007;87:1277-86
- Weir E. The public health toll of endometriosis. CMAJ 2001;164:1201
- Guidice LC, Kao LC. Endometriosis. Lancet 2004;364:1789-99
- Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health 2008;11:44-7
- Anderson MG, Miller JD. Therapeutic effects of leuprorelin microspheres on endometriosis and uterine leiomyomata. Adv Drug Deliv Rev 1997;28:139-55
- Lupron Prescribing Information. Abbott, Park, IL: Abbott Laboratories, 2008
- Surrey ES. Add-back therapy: extending safety and efficacy of GnRH analogues in the gynecologic patient. Gynecol Obstet Invest 1998;45:31-4
- Surrey ES. Add-back therapy and gonadotropin-releasing hormone agonists in the treatment of patients with endometriosis: can a consensus be reached? Add-Back Consensus Working Group. Fertil Steril 1999;71:420-4
- Kuhnz W, Heuner A, Humpel M, et al. In vivo conversion of norethisterone and norethisterone acetate to ethinyl etradiol in postmenopausal women. Contraception 1997;56:379-85
- Hollander M, Wolfe D. Nonparametric Statistical Methods (chapter 6 & 7). New York: John Wiley & Sons, 1973
- Kjerulff KH, Erickson BA, Langenberg PW. Chronic gynecological conditions reported by US women: findings from the National Health Interview Survey, 1984 to 1992. Am J Public Health 1996;86:195-9
- Hall RE, Cohen MM. Variations in hysterectomy rates in Ontario: does the indication matter?. CMAJ 1994;151:1713-9
- Gambone JC, Mittman BS, Munro MG, et al. Chronic Pelvic Pain/Endometriosis Working Group. Consensus statement for the management of chronic pelvic pain and endometriosis: proceedings of an expert-panel consensus process. Fertil Steril 2002;78:961-72